 | • レポートコード：MRC2-11QY02611 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は鎮咳薬のグローバル市場について調査・分析したレポートです。種類別（中枢作用性鎮咳薬、局所作用性鎮咳薬）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別鎮咳薬の競争状況、市場シェア ・世界の鎮咳薬市場：種類別市場規模 2015年-2020年（中枢作用性鎮咳薬、局所作用性鎮咳薬） ・世界の鎮咳薬市場：種類別市場規模予測 2021年-2026年（中枢作用性鎮咳薬、局所作用性鎮咳薬） ・世界の鎮咳薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の鎮咳薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の鎮咳薬市場分析：米国、カナダ ・ヨーロッパの鎮咳薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの鎮咳薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の鎮咳薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの鎮咳薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Toray Industries、Pfizer、Novartis、Merck、Sanofi、AstraZeneca、Zoetus、Glenmark Pharmaceuticals、Alkem Laboratories、Zydus Cadila、Cipla ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Antitussive Drugs Market
The global Antitussive Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Antitussive Drugs Scope and Market Size
Antitussive Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antitussive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antitussive Drugs market is segmented into
Centrally Acting Antitussive Drugs
Locally Acting Antitussive Drugs
Segment by Application, the Antitussive Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Antitussive Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antitussive Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antitussive Drugs Market Share Analysis
Antitussive Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antitussive Drugs business, the date to enter into the Antitussive Drugs market, Antitussive Drugs product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Toray Industries
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Zoetus
Glenmark Pharmaceuticals
Alkem Laboratories
Zydus Cadila
Cipla
1 Study Coverage
1.1 Antitussive Drugs Product Introduction
1.2 Market Segments
1.3 Key Antitussive Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antitussive Drugs Market Size Growth Rate by Type
1.4.2 Centrally Acting Antitussive Drugs
1.4.3 Locally Acting Antitussive Drugs
1.5 Market by Application
1.5.1 Global Antitussive Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antitussive Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antitussive Drugs Revenue 2015-2026
2.1.2 Global Antitussive Drugs Sales 2015-2026
2.2 Global Antitussive Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antitussive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antitussive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antitussive Drugs Competitor Landscape by Players
3.1 Antitussive Drugs Sales by Manufacturers
3.1.1 Antitussive Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antitussive Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antitussive Drugs Revenue by Manufacturers
3.2.1 Antitussive Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antitussive Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antitussive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antitussive Drugs Revenue in 2019
3.2.5 Global Antitussive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antitussive Drugs Price by Manufacturers
3.4 Antitussive Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antitussive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antitussive Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antitussive Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antitussive Drugs Market Size by Type (2015-2020)
4.1.1 Global Antitussive Drugs Sales by Type (2015-2020)
4.1.2 Global Antitussive Drugs Revenue by Type (2015-2020)
4.1.3 Antitussive Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antitussive Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antitussive Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antitussive Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antitussive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antitussive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antitussive Drugs Market Size by Application (2015-2020)
5.1.1 Global Antitussive Drugs Sales by Application (2015-2020)
5.1.2 Global Antitussive Drugs Revenue by Application (2015-2020)
5.1.3 Antitussive Drugs Price by Application (2015-2020)
5.2 Antitussive Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antitussive Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antitussive Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antitussive Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antitussive Drugs by Country
6.1.1 North America Antitussive Drugs Sales by Country
6.1.2 North America Antitussive Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antitussive Drugs Market Facts & Figures by Type
6.3 North America Antitussive Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Antitussive Drugs by Country
7.1.1 Europe Antitussive Drugs Sales by Country
7.1.2 Europe Antitussive Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antitussive Drugs Market Facts & Figures by Type
7.3 Europe Antitussive Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antitussive Drugs by Region
8.1.1 Asia Pacific Antitussive Drugs Sales by Region
8.1.2 Asia Pacific Antitussive Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antitussive Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antitussive Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antitussive Drugs by Country
9.1.1 Latin America Antitussive Drugs Sales by Country
9.1.2 Latin America Antitussive Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antitussive Drugs Market Facts & Figures by Type
9.3 Central & South America Antitussive Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antitussive Drugs by Country
10.1.1 Middle East and Africa Antitussive Drugs Sales by Country
10.1.2 Middle East and Africa Antitussive Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antitussive Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antitussive Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Antitussive Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Toray Industries
11.2.1 Toray Industries Corporation Information
11.2.2 Toray Industries Description and Business Overview
11.2.3 Toray Industries Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Toray Industries Antitussive Drugs Products Offered
11.2.5 Toray Industries Related Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description and Business Overview
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Antitussive Drugs Products Offered
11.3.5 Pfizer Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Antitussive Drugs Products Offered
11.4.5 Novartis Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Antitussive Drugs Products Offered
11.5.5 Merck Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Antitussive Drugs Products Offered
11.6.5 Sanofi Related Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Corporation Information
11.7.2 AstraZeneca Description and Business Overview
11.7.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AstraZeneca Antitussive Drugs Products Offered
11.7.5 AstraZeneca Related Developments
11.8 Zoetus
11.8.1 Zoetus Corporation Information
11.8.2 Zoetus Description and Business Overview
11.8.3 Zoetus Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zoetus Antitussive Drugs Products Offered
11.8.5 Zoetus Related Developments
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Corporation Information
11.9.2 Glenmark Pharmaceuticals Description and Business Overview
11.9.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Glenmark Pharmaceuticals Antitussive Drugs Products Offered
11.9.5 Glenmark Pharmaceuticals Related Developments
11.10 Alkem Laboratories
11.10.1 Alkem Laboratories Corporation Information
11.10.2 Alkem Laboratories Description and Business Overview
11.10.3 Alkem Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Alkem Laboratories Antitussive Drugs Products Offered
11.10.5 Alkem Laboratories Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Antitussive Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
11.12 Cipla
11.12.1 Cipla Corporation Information
11.12.2 Cipla Description and Business Overview
11.12.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Cipla Products Offered
11.12.5 Cipla Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antitussive Drugs Market Estimates and Projections by Region
12.1.1 Global Antitussive Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antitussive Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antitussive Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antitussive Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antitussive Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antitussive Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antitussive Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antitussive Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antitussive Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antitussive Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antitussive Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antitussive Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antitussive Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antitussive Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antitussive Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antitussive Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antitussive Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antitussive Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antitussive Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antitussive Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antitussive Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antitussive Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antitussive Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antitussive Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antitussive Drugs Market Segments
Table 2. Ranking of Global Top Antitussive Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antitussive Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Centrally Acting Antitussive Drugs
Table 5. Major Manufacturers of Locally Acting Antitussive Drugs
Table 6. Global Antitussive Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Antitussive Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Antitussive Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Antitussive Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Antitussive Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Antitussive Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Antitussive Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Antitussive Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Antitussive Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antitussive Drugs as of 2019)
Table 15. Antitussive Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Antitussive Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Antitussive Drugs Price (2015-2020) (USD/Units)
Table 18. Antitussive Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Antitussive Drugs Product Type
Table 20. Date of International Manufacturers Enter into Antitussive Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Antitussive Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Antitussive Drugs Sales Share by Type (2015-2020)
Table 24. Global Antitussive Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Antitussive Drugs Revenue Share by Type (2015-2020)
Table 26. Antitussive Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Units)
Table 27. Global Antitussive Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Antitussive Drugs Sales Share by Application (2015-2020)
Table 29. North America Antitussive Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Antitussive Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Antitussive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Antitussive Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Antitussive Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Antitussive Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Antitussive Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Antitussive Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Antitussive Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Antitussive Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Antitussive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Antitussive Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Antitussive Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Antitussive Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Antitussive Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Antitussive Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Antitussive Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Antitussive Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Antitussive Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Antitussive Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Antitussive Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Antitussive Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Antitussive Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Antitussive Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Antitussive Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Antitussive Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Antitussive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Antitussive Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Antitussive Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Antitussive Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Antitussive Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Antitussive Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Antitussive Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Antitussive Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Antitussive Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Antitussive Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antitussive Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Antitussive Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Antitussive Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Antitussive Drugs Sales Market Share by Application (2015-2020)
Table 69. Johnson & Johnson Corporation Information
Table 70. Johnson & Johnson Description and Major Businesses
Table 71. Johnson & Johnson Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 72. Johnson & Johnson Product
Table 73. Johnson & Johnson Recent Development
Table 74. Toray Industries Corporation Information
Table 75. Toray Industries Description and Major Businesses
Table 76. Toray Industries Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 77. Toray Industries Product
Table 78. Toray Industries Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Merck Corporation Information
Table 90. Merck Description and Major Businesses
Table 91. Merck Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 92. Merck Product
Table 93. Merck Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Major Businesses
Table 96. Sanofi Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. AstraZeneca Corporation Information
Table 100. AstraZeneca Description and Major Businesses
Table 101. AstraZeneca Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 102. AstraZeneca Product
Table 103. AstraZeneca Recent Development
Table 104. Zoetus Corporation Information
Table 105. Zoetus Description and Major Businesses
Table 106. Zoetus Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 107. Zoetus Product
Table 108. Zoetus Recent Development
Table 109. Glenmark Pharmaceuticals Corporation Information
Table 110. Glenmark Pharmaceuticals Description and Major Businesses
Table 111. Glenmark Pharmaceuticals Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 112. Glenmark Pharmaceuticals Product
Table 113. Glenmark Pharmaceuticals Recent Development
Table 114. Alkem Laboratories Corporation Information
Table 115. Alkem Laboratories Description and Major Businesses
Table 116. Alkem Laboratories Antitussive Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 117. Alkem Laboratories Product
Table 118. Alkem Laboratories Recent Development
Table 119. Zydus Cadila Corporation Information
Table 120. Zydus Cadila Description and Major Businesses
Table 121. Zydus Cadila Antitussive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 122. Zydus Cadila Product
Table 123. Zydus Cadila Recent Development
Table 124. Cipla Corporation Information
Table 125. Cipla Description and Major Businesses
Table 126. Cipla Antitussive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 127. Cipla Product
Table 128. Cipla Recent Development
Table 129. Global Antitussive Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 130. Global Antitussive Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Antitussive Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Antitussive Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Antitussive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 134. North America: Antitussive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Antitussive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Europe: Antitussive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Antitussive Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 138. Asia Pacific: Antitussive Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Antitussive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 140. Latin America: Antitussive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Antitussive Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 142. Middle East and Africa: Antitussive Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Antitussive Drugs Players
Table 147. Antitussive Drugs Customers List
Table 148. Antitussive Drugs Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Antitussive Drugs Product Picture
Figure 2. Global Antitussive Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Centrally Acting Antitussive Drugs Product Picture
Figure 4. Locally Acting Antitussive Drugs Product Picture
Figure 5. Global Antitussive Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Antitussive Drugs Report Years Considered
Figure 10. Global Antitussive Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Antitussive Drugs Sales 2015-2026 (K Units)
Figure 12. Global Antitussive Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Antitussive Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Antitussive Drugs Sales Market Share by Region in 2019
Figure 15. Global Antitussive Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Antitussive Drugs Revenue Market Share by Region in 2019
Figure 17. Global Antitussive Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Antitussive Drugs Revenue in 2019
Figure 19. Antitussive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Antitussive Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Antitussive Drugs Sales Market Share by Type in 2019
Figure 22. Global Antitussive Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Antitussive Drugs Revenue Market Share by Type in 2019
Figure 24. Global Antitussive Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Antitussive Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Antitussive Drugs Sales Market Share by Application in 2019
Figure 27. Global Antitussive Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Antitussive Drugs Revenue Market Share by Application in 2019
Figure 29. North America Antitussive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Antitussive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Antitussive Drugs Sales Market Share by Country in 2019
Figure 32. North America Antitussive Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Antitussive Drugs Market Share by Type in 2019
Figure 38. North America Antitussive Drugs Market Share by Application in 2019
Figure 39. Europe Antitussive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Antitussive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Antitussive Drugs Sales Market Share by Country in 2019
Figure 42. Europe Antitussive Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Antitussive Drugs Market Share by Type in 2019
Figure 54. Europe Antitussive Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Antitussive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Antitussive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Antitussive Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Antitussive Drugs Revenue Market Share by Region in 2019
Figure 59. China Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Antitussive Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Antitussive Drugs Market Share by Application in 2019
Figure 83. Latin America Antitussive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Antitussive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Antitussive Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Antitussive Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Antitussive Drugs Market Share by Type in 2019
Figure 94. Latin America Antitussive Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Antitussive Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Antitussive Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Antitussive Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Antitussive Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Antitussive Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Antitussive Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Antitussive Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Antitussive Drugs Market Share by Application in 2019
Figure 107. North America Antitussive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Antitussive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Antitussive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Antitussive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Antitussive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Antitussive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Antitussive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Antitussive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Antitussive Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Antitussive Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- バルビツール酸系薬物の世界市場（～2026年） Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates ar…
- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…